Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients

被引：0
|
作者：
Sara E. Mole
Angela Schulz
Eben Badoe
Samuel F. Berkovic
Emily C. de Los Reyes
Simon Dulz
Paul Gissen
Norberto Guelbert
Charles M. Lourenco
Heather L. Mason
Jonathan W. Mink
Noreen Murphy
Miriam Nickel
Joffre E. Olaya
Maurizio Scarpa
Ingrid E. Scheffer
Alessandro Simonati
Nicola Specchio
Ina Von Löbbecke
Raymond Y. Wang
Ruth E. Williams
机构：
[1] University College London,Korle Bu Teaching Hospital
[2] Universitätsklinikum Hamburg-Eppendorf,Austin Health Victoria
[3] University of Ghana Medical School,Golisano Childrens’ Hospital
[4] University of Melbourne,Regional Coordinating Center for Rare Diseases
[5] Nationwide Children’s Hospital,Department of Surgery, Dentistry, Paediatrics and Gynaecology
[6] Hospital de Niños de La Santísima Trinidad,undefined
[7] Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto,undefined
[8] Coufetery Comms,undefined
[9] University of Rochester Medical Center,undefined
[10] Batten Disease Support and Research Association (BDSRA),undefined
[11] Children’s Hospital of Orange County,undefined
[12] University Hospital Udine,undefined
[13] University of Verona School of Medicine,undefined
[14] Ospedale Pediatrico Bambino Gesù,undefined
[15] Practice for Child Physiotherapy,undefined
[16] Evelina,undefined
[17] London Children’s Hospital,undefined
[18] NIHR Great Ormond Street Hospital Biomedical Research Centre,undefined
[19] Royal Children’s Hospital,undefined
[20] Florey and Murdoch Children’s Research Institutes,undefined
来源：
Orphanet Journal of Rare Diseases | / 16卷
关键词：
Expert mapping; Guideline development program; CLN2; Batten; Neurodegenerative disorder; Key Opinion Leader; Modified-Delphi;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Study of Intraventricular Cerliponase Alfa for CLN2 Disease
    Schulz, Angela
    Ajayi, Temitayo
    Specchio, Nicola
    de Los Reyes, Emily
    Gissen, Paul
    Ballon, Douglas
    Dyke, Jonathan P.
    Cahan, Heather
    Slasor, Peter
    Jacoby, David
    Kohlschutter, Alfried
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (20): : 1898 - 1907
  • [22] Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series
    Wibbeler, Eva
    Wang, Raymond
    de los Reyes, Emily
    Specchio, Nicola
    Gissen, Paul
    Guelbert, Norberto
    Nickel, Miriam
    Schwering, Christoph
    Lehwald, Lenora
    Trivisano, Marina
    Lee, Laura
    Amato, Gianni
    Cohen-Pfeffer, Jessica
    Shediac, Renee
    Leal-Pardinas, Fernanda
    Schulz, Angela
    JOURNAL OF CHILD NEUROLOGY, 2021, 36 (06) : 468 - 474
  • [23] Cerliponase alfa for the treatment of atypical phenotypes of CLN2 disease: A retrospective case series
    Wibbeler, Eva
    Wang, Raymond
    de los Reyes, Emily
    Specchio, Nicola
    Gissen, Paul
    Guelbert, Norberto
    Nickel, Miriam
    Schwering, Christoph
    Lehwald, Lenora
    Trivisano, Marina
    Lee, Laura
    Amato, Gianni
    Cohen-Pfeffer, Jessica
    Shediac, Renee
    Leal-Pardinas, Fernanda
    Schulz, Angela
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S161 - S162
  • [24] Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis
    Fietz, Michael
    AlSayed, Moeenaldeen
    Burke, Derek
    Cohen-Pfeffer, Jessica
    Cooper, Jonathan D.
    Dvorakova, Lenka
    Giugliani, Roberto
    Izzo, Emanuela
    Jahnova, Helena
    Lukacs, Zoltan
    Mole, Sara E.
    de Halac, Ines Noher
    Pearce, David A.
    Poupetova, Helena
    Schulz, Angela
    Specchio, Nicola
    Xin, Winnie
    Miller, Nicole
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (1-2) : 160 - 167
  • [25] Intrafamilial variability in late-onset CLN2 disease
    Goobie, Sharan
    Bujold, Jillian
    Dyack, Sarah
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S66 - S67
  • [26] Provoked seizures might lead to a significant diagnosis delay in CLN2
    Rener-Primec, Zvonka
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2022, 40 : A4 - A5
  • [27] Evolved AAV Capsids for Gene Therapy of CLN2 Disease
    Tecedor, Luis
    Chen, Yong Hong
    Ranum, Paul T.
    Megan, Keiser S.
    Leib, David E.
    Cheng, Congsheng
    Lysenko, Elena
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2022, 30 (04) : 128 - 129
  • [28] Intracerebroventricular cerliponase alfa for CLN2 disease: Clinical practice considerations from US clinics
    Wang, Raymond Y.
    de los Reyes, Emily
    Lehwald, Lenora
    Augustine, Erika
    Berry-Kravis, Elizabeth
    Butler, Karen
    Cormier, Natalie
    Demarest, Scott
    Lu, Sam
    Madden, Jacqueline
    Olaya, Joffre
    See, Susan
    Vierhile, Amy
    Wheless, James
    Yang, Amy
    Cohen-Pfeffer, Jessica
    Chu, Dorna
    Leal-Pardinas, Fernanda
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S158 - S158
  • [29] Intracerebroventricular Cerliponase Alfa for CLN2 Disease: Clinical Practice Considerations from US Clinics
    de los Reyes, E.
    Lehwald, L.
    Wang, R.
    Augustine, E.
    Berry-Kravis, E.
    Butler, K.
    Cormier, N.
    Demarest, S.
    Lu, S.
    Madden, J.
    Olaya, J.
    See, S.
    Vierhile, A.
    Yang, A.
    Leal-Pardinas, F.
    ANNALS OF NEUROLOGY, 2019, 86 : S136 - S136
  • [30] Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients
    Schwering, Christoph
    Kammler, Gertrud
    Wibbeler, Eva
    Christner, Martin
    Knobloch, Johannes K. -M.
    Nickel, Miriam
    Denecke, Jonas
    Baehr, Michael
    Schulz, Angela
    JOURNAL OF CHILD NEUROLOGY, 2021, 36 (08) : 635 - 641
12345